Search Results 81 – 100 of 696
Didanosine Drug Summary Updated
Date:
Source: ClinicalInfo
https://clinicalinfo.hiv.gov/drugs/didanosine/patient
Pyridostigmine Drug Summary Updated
Date:
Source: ClinicalInfo
https://clinicalinfo.hiv.gov/drugs/pyridostigmine/patient
Exposure to HIV Drug in the Womb May Increase Risk of Microcephaly, Developmental Delays in Children
Date:
Source: Exposure to HIV Drug in the Womb May Increase Risk of Microcephaly, Developmental Delays in Children
https://clinicalinfo.hiv.gov/news/exposure-hiv-drug-womb-may-increase-risk-microcephaly-developmental-delays-children
Complera Drug Summary Updated
Date:
Source: ClinicalInfo
https://clinicalinfo.hiv.gov/drugs/emtricitabine-rilpivirine-tenofovir-disoproxil-fumarate/patient
Lefitolimod Drug Summary Updated
Date:
Source: ClinicalInfo
https://clinicalinfo.hiv.gov/drugs/lefitolimod/patient
Elbasvir / Grazoprevir Drug Summary Updated
Date:
Source: ClinicalInfo
https://clinicalinfo.hiv.gov/drugs/elbasvir-grazoprevir/patient
Fostemsavir Drug Summary Updated
Date:
Source: ClinicalInfo
https://clinicalinfo.hiv.gov/drugs/fostemsavir/patient
FDA Authorizes Marketing of First Next-Generation Sequencing Test for Detecting HIV-1 Drug Resistance Mutations
Date:
Source: FDA Authorizes Marketing of First Next-Generation Sequencing Test for Detecting HIV-1 Drug Resistance Mutations
https://clinicalinfo.hiv.gov/news/fda-authorizes-marketing-first-next-generation-sequencing-test-detecting-hiv-1-drug-resistance
Emtricitabine Drug Summary Updated
Date:
Source: ClinicalInfo
https://clinicalinfo.hiv.gov/drugs/emtricitabine/patient
Ombitasvir/Paritaprevir/Ritonavir plus Dasabuvir Drug Summary Updated
Date:
Source: ClinicalInfo
https://clinicalinfo.hiv.gov/drugs/ombitasvirparitaprevirritonavir-plus-dasabuvir/patient
Amphotericin B Drug Summary Updated
Date:
Source: ClinicalInfo
https://clinicalinfo.hiv.gov/drugs/amphotericin-b/patient
Ending HIV Will Require Optimizing Treatment and Prevention Tools
Date:
Source: Ending HIV Will Require Optimizing Treatment and Prevention Tools
https://clinicalinfo.hiv.gov/news/ending-hiv-will-require-optimizing-treatment-and-prevention-tools
Amphotericin B Drug Summary Updated
Date:
Source: ClinicalInfo
Author: National Institutes of Health (NIH)
https://clinicalinfo.hiv.gov/drugs/amphotericin-b/patient
Sulfamethoxazole / Trimethoprim Drug Summary Updated
Date:
Source: ClinicalInfo
https://clinicalinfo.hiv.gov/drugs/sulfamethoxazole-trimethoprim/patient
Clindamycin Drug Summary Updated
Date:
Source: ClinicalInfo
https://clinicalinfo.hiv.gov/drugs/clindamycin/patient
Clarithromycin Drug Summary Updated
Date:
Source: ClinicalInfo
https://clinicalinfo.hiv.gov/drugs/clarithromycin/patient
Azithromycin Drug Summary Updated
Date:
Source: ClinicalInfo
https://clinicalinfo.hiv.gov/drugs/azithromycin/patient
Vancomycin Hydrochloride Drug Summary Updated
Date:
Source: ClinicalInfo
https://clinicalinfo.hiv.gov/drugs/vancomycin-hydrochloride/patient
Sofosbuvir / Velpatasvir / Voxilaprevir Drug Summary Updated
Date:
Source: ClinicalInfo
https://clinicalinfo.hiv.gov/drugs/sofosbuvir-velpatasvir-voxilaprevir/patient
Mavyret Drug Summary Updated
Date:
Source: ClinicalInfo
https://clinicalinfo.hiv.gov/drugs/glecaprevir-pibrentasvir/patient